S&P 500
(0.80%) 5 277.51 points
Dow Jones
(1.51%) 38 686 points
Nasdaq
(-0.01%) 16 735 points
Oil
(-0.94%) $77.18
Gas
(0.35%) $2.58
Gold
(-0.79%) $2 347.70
Silver
(-3.10%) $30.56
Platinum
(0.63%) $1 044.50
USD/EUR
(-0.17%) $0.921
USD/NOK
(-0.49%) $10.49
USD/GBP
(-0.05%) $0.785
USD/RUB
(0.15%) $90.40

Realtime updates for Immunome, Inc. [IMNM]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
BUY
66.67%
return 0.92%
SELL
50.00%
return -1.61%
Last Updated31 May 2024 @ 16:00

1.56% $ 14.94

BUY 154892 min ago

@ $22.58

Issued: 14 Feb 2024 @ 14:40


Return: -33.82%


Previous signal: Feb 14 - 10:32


Previous signal: Sell


Return: 6.29 %

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):
Profile picture for Immunome, Inc.

Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system...

Stats
Today's Volume 1.54M
Average Volume 745 577
Market Cap 895.94M
EPS $0 ( 2024-05-17 )
Next earnings date ( $-0.690 ) 2024-08-07
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.850
ATR14 $0.0610 (0.41%)
Insider Trading
Date Person Action Amount type
2024-05-21 Bienaime Jean Jacques Buy 2 000 Common Stock
2024-05-21 Siegall Clay B Buy 20 434 Common Stock
2024-05-20 Siegall Clay B Buy 79 566 Common Stock
2024-05-16 Rosett Max Buy 30 000 Stock option (right to buy)
2024-04-25 Swain Sandra M Buy 25 737 Stock option (right to buy)
INSIDER POWER
-12.49
Last 92 transactions
Buy: 3 693 654 | Sell: 4 251 388

Volume Correlation

Long: -0.40 (neutral)
Short: -0.58 (weak negative)
Signal:(56.511) Neutral

Immunome, Inc. Correlation

10 Most Positive Correlations
VXRT0.917
FATE0.894
IDYA0.887
BHFAP0.883
CSX0.874
BASE0.874
ORMP0.868
PXLW0.866
GANX0.865
CFBK0.864
10 Most Negative Correlations
RELL-0.843
STKS-0.831
BFRI-0.822
PSHG-0.81

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Immunome, Inc. Correlation - Currency/Commodity

The country flag -0.68
( moderate negative )
The country flag -0.24
( neutral )
The country flag 0.00
( neutral )
The country flag -0.61
( weak negative )
The country flag 0.06
( neutral )
The country flag -0.05
( neutral )

Immunome, Inc. Financials

Annual 2023
Revenue: $14.02M
Gross Profit: $13.29M (94.81 %)
EPS: $-5.38
FY 2023
Revenue: $14.02M
Gross Profit: $13.29M (94.81 %)
EPS: $-5.38
FY 2022
Revenue: $0
Gross Profit: $-631 000 (0.00 %)
EPS: $-3.09
FY 2021
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-5.63

Financial Reports:

No articles found.

Immunome, Inc. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Immunome, Inc.

Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 1.4014778137207 seconds
Number of API calls: 2
Number of DB calls: 8